Skip to main content
. 2013 Mar 1;14(3):271–277. doi: 10.4161/cbt.23300

graphic file with name cbt-14-271-g3.jpg

Figure 3. The antibody-dye conjugates were evaluated in human tumor explants. Imaging with the SPY and Pearl in mice with human cSCC tumor explants shows good tumor uptake and detection (A). Panitumumab-IRDye800 produced a higher TBR with the SPY and Pearl (B).